Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
35
days
Persistent low-level real human chorionic gonadotropin after gestational trophoblastic disease: Natural history and predictors of subsequent gestational trophoblastic neoplasia
Authors
Raphael Alevato; Antônio Braga; Gabriela Paiva; Edward Araujo Júnior; Sue Yazaki Sun; Luana Giongo Pedrotti; Marina Bessel; Solange Artimos de Oliveira; Joffre Amim-Junior; Jorge Rezende-Filho; Ross Berkowitz; Neil HorowitzShow moreShow less
Affiliations
School of Medicine, Fluminense Federal University, Niterói, RJ 24070-090, Brazil; Department of Gynecology and Obstetrics, School of Medicine, Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 22240-003, Brazil; Department of General and Specialized Surgery, School of Medicine and Surgery, Federal University of the State of Rio de Janeiro, Rio de Janeiro, RJ 20270-004, Brazil; University of Vassouras, Vassouras, RJ 27700-000, Brazil; Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo 04023-062, SP, Brazil; Hospital Moinhos de Vento, Porto Alegre, RS, Brazil; New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USAShow moreShow less
37
days
Dynamics of HER2 status in recurrent cervical cancer: Highlighting the clinical value of reassessment
Authors
Jun-Hyeong Seo; Yurimi Lee; Seongyun Lim; Young Eun Chung; Yoo-Young Lee; Chel-Hun Choi; Hyun-Soo Kim; Jeong-Won LeeShow moreShow less
Affiliations
Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University School of Medicine, Seoul, Republic of KoreaShow moreShow less
72
days
A phase II study of androgen receptor inhibition by darolutamide in combination with leuprolide acetate and exemestane in recurrent adult-type ovarian granulosa cell tumor
Authors
Elizabeth E. Hopp; Danielle Enserro; Susana Campos; Viola Chitiyo; Gloria Huang; Heather Lankes; Erin K. Crane; Anna Hoekstra; Jean Siedel; Debra L. Richardson; Carol Aghajanian; Janet S. Rader; Allan CovensShow moreShow less
Affiliations
Medical College of Wisconsin Cancer Center, Department of Obstetrics and Gynecology, 8701 W Watertown Plank Rd Milwaukee, WI 53226, USA; NRG Oncology, CTDD Biostatistics & Bioinformatics; Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA; Dana Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Yale Cancer Center, 35 Park St, New Haven, CT 06519, USA; Division of Gynecologic Oncology, Ohio State University Comprehensive Cancer Center, Columbus, OH 43210, USA; Levine Cancer Atrium Health Wake Forest Baptist, 1021 Morehead Medical Drive Charlotte, NC 28204, USA; CRC West Michigan Cancer Center, 200 North Park St, Kalamazoo, MI 49007, USA; University of Michigan, 1500 E Medical Center Dr, Ann Arbor, MI 48109, USA; University of Oklahoma, 800 NE 10th Street, Oklahoma City, OK 73104, USA; University of Toronto, Sunnybrook Health Centre, Odette Cancer Centre, 2075 Bayview Ave, Toronto, ON, M4N 3M5, CanadaShow moreShow less
72
days
Quality of life outcomes after sentinel lymph node biopsy in patients with early-stage cervical cancer: Results from the prospective multicentre SENTIX study
Authors
Roman Kocian; Christhardt Koehler; Giampaolo Di Martino; Jaroslav Klat; Luc van Lonkhuijzen; Jiri Jarkovsky; Michal Zikan; Ignacio Zapardiel; Octavio Arencibia Sanchez; Blanca Gil-Ibanez; Francesco Raspagliesi; Jiri Presl; Lubos Minar; Radim Marek; Peter Kascak; Pavel Havelka; Martin Michal; Toon Van Gorp; Kristyna Nemejcova; Pavel Dundr; Sambor Sawicki; Martina Borcinová; David CibulaShow moreShow less
Affiliations
Gynecologic Oncology Center, Department of Gynecology, Obstetrics and Neonatology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Department of Obstetrics and Gynecology, Albertinen Hospital Hamburg, Germany; Department of Obstetrics and Gynecology, University Hospital Ostrava, Ostrava, Poruba, Czech Republic; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Gynecologic Oncology Unit, La Paz University Hospital, Madrid, Spain; Department of Gynecologic Oncology, Amsterdam University Medical Center, Center for Gynecological Oncology Amsterdam, Amsterdam, Netherlands; Department of Obstetrics and Gynecology, Bulovka University Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic; Department of Gynecologic Oncology, University Hospital of the Canary Islands, Las Palmas de Gran Canaria, Spain; Unit of Gynecological Oncology, Institute Clinic of Gynecology, Obstetrics and Neonatology (ICGON), Hospital Clinic of Barcelona, Barcelona, Spain; Department of Gynecological Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy; Department of Gynecology and Obstetrics, University Hospital Pilsen, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic; Department of Gynecology and Obstetrics, Faculty of Medicine, Masaryk University, University Hospital Brno, Brno, Czech Republic; Department of Obstetrics and Gynecology, Faculty of Medicine and Dentistry, Palacky University, University Hospital Olomouc, Olomouc, Czech Republic; Department of Gynecology and Obstetrics, Slovak Medical University and University Hospital, Bratislava, Slovak Republic; Department of Obstetrics and Gynecology, KNTB a.s, Zlin, Czech Republic; Department of Obstetrics and Gynecology, Hospital Ceske Budejovice, JSC, Ceske Budejovice, Czech Republic; Department of Gynaecological Oncology, University Hospital Leuven, Leuven Cancer Institute, Leuven, Belgium; Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic; Gynecologic Oncology Surgical Division, Humanitas San Pio X, Milan 20159, Italy; Gynecology Unit, IRCCS Fondazione San Gerardo dei Tintori, 20900 Monza, Italy; Department of Obstetrics, Gynaecology and Neonatology, Medical University of Gdansk, PolandShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days